top of page

Day One: 2025 Life Science, Digital & Health Open Innovation Forum

  • Writer: SD&K Holdings
    SD&K Holdings
  • Mar 3
  • 2 min read

On March 3rd, we held day one of our forum at the Royal Society in London, with the aim of uniting the collective expertise of ‘UK, Korea and Japan - Life Science, Digital Technology & Healthcare’ to tackle critical health and disease-related challenges. 


The Forum was co-hosted by Medical Research Council and King's College London.


On the first day, we had a turnout of over 80 guests where we successfully fostered a multidisciplinary ‘Open Innovation’ platform that bridged academia, industry and government organisations from UK , Korea and Japan. 


We were excited to receive participation and presentation from the Department for Science, Innovation and Technology, the Department for Business and TradeDepartment of Health and Social Care, Medical Research Council, King's College London, Drug Discovery Institute Oxford, Rosalind Franklin InstituteHarwell Science and Innovation Campus from the UK🇬🇧, and JETRO - Japan External Trade Organization  London, Japan Agency for Medical Research and Development (AMED) from Japan. 


The programme was organised by Prof. Chas Bountra (University of Oxford), Prof. Kei Cho (King’s College London), Mr. Jonathan Crook (Department for Business & Trade), Mr. Sebastian Johnson (Advanced Research Clusters Harwell) and Dr. Mark Palmer (Medical Research

Council). Prof. Kei Cho opened the Forum at the Royal Society, Wolfson Library, London.


The Forum served as the cornerstone for the development of ‘Strategic Partnerships’ and improved OPEN INNOVATION ECOSYSTEM and “Golden-Triangle” R&D Opportunities (UK-Japan-Korea). United Kingdom, Japan and South Korean government bodies, associated agents and industries exchanged the idea of trilateral collaboration.


The Forum discussed how can Life Science-Digital/Artificial Intelligence (AI) & Technology be

used synergistically to provide a better understanding of biological mechanisms associated with health/disease and foster open-innovation platforms, providing better solutions to improve the quality of life.








 
 
 

Comments


bottom of page